Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Lineage Cell Therapeutics Inc

1.02
-0.0150-1.46%
Volume:400.86K
Turnover:407.11K
Market Cap:256.70M
PE:-5.47
High:1.03
Open:1.02
Low:1.01
Close:1.03
52wk High:2.09
52wk Low:1.00
Shares:252.91M
Float Shares:191.00M
Volume Ratio:1.32
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1855
EPS(LYR):-0.2761
ROE:-60.06%
ROA:-17.04%
PB:4.21
PE(LYR):-3.68

Loading ...

OverviewCompanyNewsFilings

Lineage Cell Therapeutics to report Q1 results, host conference call May 12

Reuters
·
May 05

Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026

THOMSON REUTERS
·
May 05

Lineage says Phase 2a GAlette trial of OpRegen in geographic atrophy enrolls patients

Reuters
·
May 04

Lineage Cell Therapeutics announces annual shareholder meeting

Reuters
·
Apr 30

Lineage Cell Therapeutics Initiated at Buy by Canaccord Genuity

Dow Jones
·
Apr 29

Lineage names Priyantha Herath senior VP, head of clinical operations

Reuters
·
Apr 13

Lineage Announces Formation of Scientific Advisory Board

THOMSON REUTERS
·
Apr 13

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX) and Immutep Ltd (OtherPRRUF)

TIPRANKS
·
Mar 15

Analyst Rate

Buy
Buy
85.72%
Hold
14.29%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Post-Mkt
Financial Report Announcement
May 12, 2026 Post-Mkt
Financial Report Announcement
Mar 05, 2026 Post-Mkt
Financial Report Announcement
Nov 06, 2025 Post-Mkt
Financial Report Announcement
Aug 12, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-5.55
Current
-9.54
Sector Average
37.23%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-5.55
Maximum
-3.59
+1 STD
-2.26
Minimum
-37.65
-1 STD
-16.82
Average
-9.54

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.